Arali Ventures, an enterprise-tech investor, has announced a complete exit from HBOX Inc., with a 23X return in four years, with an internal rate of return (IRR) of about 120%.
The exit coincides with HBOX securing strategic growth investment from the Charlesbank Technology Opportunities Fund, reinforcing the depth of Arali’s enterprise-tech thesis and its ability to back globally scalable businesses from their earliest stages, it said in a statement.
HBOX is a US-headquartered remote health technology startup, with its core engineering and delivery teams based in India.
“Our approach at Arali has always been rooted in early conviction and close founder partnerships, and we remain focussed on backing enterprise-facing businesses that are built from India, can sustainably scale and become category leaders,” said Rajiv Raghunandan, managing partner, Arali Ventures. “The portfolio we have built highlights India’s AI strength—innovated locally and built for the world. We will continue building resilient, globally relevant enterprise-tech companies as our thesis enters its next chapter.”
Arali invested in HBOX at inception, driven by a strong belief in the founding team’s vision to transform speciality care delivery through a robust artificial intelligence (AI)-first virtual care enablement platform. Over the years, HBOX has scaled rapidly while maintaining disciplined execution and capital efficiency — hallmarks aligned with Arali’s investment philosophy.
This milestone exit further strengthens the performance of Arali Fund I, which has already executed partial exits in FinBox and complete exits in Wingman and Insent, delivering greater than 2X of the fund within six years, positioning it among the top-decile funds of the 2019 vintage, the statement said.
Arali’s Fund I continues to back a strong cohort of high-potential enterprise-tech companies, including FinBox, Unbox Robotics, Bimakavach, and Cynlr, among others. Fund II builds on this momentum with investments in next-generation enterprise-tech disruptors such as Pibit, Fluxgen, Harvested Labs, Quash, 50Fin, and others, the statement added.
The exit coincides with HBOX securing strategic growth investment from the Charlesbank Technology Opportunities Fund, reinforcing the depth of Arali’s enterprise-tech thesis and its ability to back globally scalable businesses from their earliest stages, it said in a statement.
HBOX is a US-headquartered remote health technology startup, with its core engineering and delivery teams based in India.
“Our approach at Arali has always been rooted in early conviction and close founder partnerships, and we remain focussed on backing enterprise-facing businesses that are built from India, can sustainably scale and become category leaders,” said Rajiv Raghunandan, managing partner, Arali Ventures. “The portfolio we have built highlights India’s AI strength—innovated locally and built for the world. We will continue building resilient, globally relevant enterprise-tech companies as our thesis enters its next chapter.”
Arali invested in HBOX at inception, driven by a strong belief in the founding team’s vision to transform speciality care delivery through a robust artificial intelligence (AI)-first virtual care enablement platform. Over the years, HBOX has scaled rapidly while maintaining disciplined execution and capital efficiency — hallmarks aligned with Arali’s investment philosophy.
This milestone exit further strengthens the performance of Arali Fund I, which has already executed partial exits in FinBox and complete exits in Wingman and Insent, delivering greater than 2X of the fund within six years, positioning it among the top-decile funds of the 2019 vintage, the statement said.
Arali’s Fund I continues to back a strong cohort of high-potential enterprise-tech companies, including FinBox, Unbox Robotics, Bimakavach, and Cynlr, among others. Fund II builds on this momentum with investments in next-generation enterprise-tech disruptors such as Pibit, Fluxgen, Harvested Labs, Quash, 50Fin, and others, the statement added.
